US Stock MarketDetailed Quotes

SYMQY SYMBIO PHARMACEUTICALS LTD SPON ADR EACH REPR 1 ORD

Watchlist
  • 1.210
  • 0.0000.00%
15min DelayClose Jul 26 09:30 ET
55.43MMarket Cap-2762P/E (TTM)

SYMBIO PHARMACEUTICALS LTD SPON ADR EACH REPR 1 ORD Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
(FY)Dec 31, 2018
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Net income from continuing operations
-156.75%-1.2B
110.35%2.11B
124.50%1B
6.54%-4.09B
-59.07%-4.37B
---2.75B
Other non cash items
-157.04%-88.42M
1,014.76%155.02M
103.04%13.91M
-2,628.41%-457.69M
-42.69%18.1M
--31.59M
Change In working capital
1,506.87%841.04M
94.40%-59.78M
-366.75%-1.07B
5.46%-228.53M
-231.11%-241.72M
--184.37M
-Change in receivables
1,772.10%1.17B
103.60%62.59M
-1,323.26%-1.74B
149.40%142.29M
-656.67%-288.02M
--51.74M
-Change in inventory
386.75%237.28M
-114.80%-82.75M
159.21%559.24M
-276.92%-944.44M
411.61%533.82M
---171.31M
-Change in prepaid assets
239.68%90.61M
-0.79%-64.87M
-223.33%-64.37M
285.94%52.19M
-63.62%-28.07M
---17.15M
-Change in other current assets
34.52%-236.2M
-142.91%-360.7M
445.92%840.62M
-1,623.98%-243.01M
-47.49%15.95M
--30.37M
-Change in other current liabilities
37.32%-66.34M
19.92%-105.84M
-169.44%-132.18M
3,547.08%190.34M
-62.55%5.22M
--13.94M
Cash from discontinued investing activities
Operating cash flow
-112.06%-194.69M
1,052.68%1.61B
103.40%140.04M
5.25%-4.12B
-87.16%-4.35B
---2.32B
Investing cash flow
Cash flow from continuing investing activities
Net PPE purchase and sale
-9,941.79%-204.25M
92.01%-2.03M
-62.47%-25.45M
36.05%-15.67M
23.28%-24.5M
---31.93M
Net intangibles purchase and sale
37.29%-28.55M
-18.60%-45.52M
71.20%-38.38M
30.60%-133.26M
-2,350.08%-192.01M
---7.84M
Net other investing changes
-33,487.24%-143.9M
106.15%431K
38.37%-7.01M
-23,320.41%-11.38M
-99.64%49K
--13.59M
Cash from discontinued investing activities
Investing cash flow
-699.32%-376.7M
33.48%-47.13M
55.80%-70.85M
25.94%-160.31M
-726.82%-216.46M
---26.18M
Financing cash flow
Cash flow from continuing financing activities
Net common stock issuance
10.73%680.16M
954.00%614.23M
-101.71%-71.92M
12.61%4.21B
-11.98%3.74B
--4.25B
Net other financing activities
-100.01%-1K
1,375,900.00%13.76M
-99.99%1K
--10.54M
----
--23.1M
Cash from discontinued financing activities
Financing cash flow
8.31%680.16M
973.15%627.99M
-101.70%-71.92M
12.89%4.22B
-12.45%3.74B
--4.27B
Net cash flow
Beginning cash position
62.76%6.28B
0.30%3.86B
-1.59%3.85B
-18.89%3.91B
63.60%4.82B
--2.95B
Current changes in cash
-95.04%108.78M
80,536.02%2.2B
95.50%-2.73M
92.66%-60.7M
-143.05%-827.16M
--1.92B
Effect of exchange rate changes
-41.19%125.67M
1,404.05%213.71M
1,046.64%14.21M
98.20%-1.5M
-77.26%-83.37M
---47.03M
End cash Position
3.73%6.52B
62.76%6.28B
0.30%3.86B
-1.59%3.85B
-18.89%3.91B
--4.82B
Free cash flow
-127.29%-427.48M
1,955.88%1.57B
101.78%76.21M
6.48%-4.27B
-93.17%-4.57B
---2.36B
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019(FY)Dec 31, 2018
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
Net income from continuing operations -156.75%-1.2B110.35%2.11B124.50%1B6.54%-4.09B-59.07%-4.37B---2.75B
Other non cash items -157.04%-88.42M1,014.76%155.02M103.04%13.91M-2,628.41%-457.69M-42.69%18.1M--31.59M
Change In working capital 1,506.87%841.04M94.40%-59.78M-366.75%-1.07B5.46%-228.53M-231.11%-241.72M--184.37M
-Change in receivables 1,772.10%1.17B103.60%62.59M-1,323.26%-1.74B149.40%142.29M-656.67%-288.02M--51.74M
-Change in inventory 386.75%237.28M-114.80%-82.75M159.21%559.24M-276.92%-944.44M411.61%533.82M---171.31M
-Change in prepaid assets 239.68%90.61M-0.79%-64.87M-223.33%-64.37M285.94%52.19M-63.62%-28.07M---17.15M
-Change in other current assets 34.52%-236.2M-142.91%-360.7M445.92%840.62M-1,623.98%-243.01M-47.49%15.95M--30.37M
-Change in other current liabilities 37.32%-66.34M19.92%-105.84M-169.44%-132.18M3,547.08%190.34M-62.55%5.22M--13.94M
Cash from discontinued investing activities
Operating cash flow -112.06%-194.69M1,052.68%1.61B103.40%140.04M5.25%-4.12B-87.16%-4.35B---2.32B
Investing cash flow
Cash flow from continuing investing activities
Net PPE purchase and sale -9,941.79%-204.25M92.01%-2.03M-62.47%-25.45M36.05%-15.67M23.28%-24.5M---31.93M
Net intangibles purchase and sale 37.29%-28.55M-18.60%-45.52M71.20%-38.38M30.60%-133.26M-2,350.08%-192.01M---7.84M
Net other investing changes -33,487.24%-143.9M106.15%431K38.37%-7.01M-23,320.41%-11.38M-99.64%49K--13.59M
Cash from discontinued investing activities
Investing cash flow -699.32%-376.7M33.48%-47.13M55.80%-70.85M25.94%-160.31M-726.82%-216.46M---26.18M
Financing cash flow
Cash flow from continuing financing activities
Net common stock issuance 10.73%680.16M954.00%614.23M-101.71%-71.92M12.61%4.21B-11.98%3.74B--4.25B
Net other financing activities -100.01%-1K1,375,900.00%13.76M-99.99%1K--10.54M------23.1M
Cash from discontinued financing activities
Financing cash flow 8.31%680.16M973.15%627.99M-101.70%-71.92M12.89%4.22B-12.45%3.74B--4.27B
Net cash flow
Beginning cash position 62.76%6.28B0.30%3.86B-1.59%3.85B-18.89%3.91B63.60%4.82B--2.95B
Current changes in cash -95.04%108.78M80,536.02%2.2B95.50%-2.73M92.66%-60.7M-143.05%-827.16M--1.92B
Effect of exchange rate changes -41.19%125.67M1,404.05%213.71M1,046.64%14.21M98.20%-1.5M-77.26%-83.37M---47.03M
End cash Position 3.73%6.52B62.76%6.28B0.30%3.86B-1.59%3.85B-18.89%3.91B--4.82B
Free cash flow -127.29%-427.48M1,955.88%1.57B101.78%76.21M6.48%-4.27B-93.17%-4.57B---2.36B
Currency Unit JPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg